We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

55 hedge funds and large institutions have $401M invested in Compass Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

340% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 5

287% more capital invested

Capital invested by funds: $104M → $401M (+$298M)

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

45% more funds holding

Funds holding: 38 → 55 (+17)

3.47% less ownership

Funds ownership: 66.73% → 63.26% (-3.5%)

Holders
55
Holders Change
+17
Holders Change %
+44.74%
% of All Funds
0.88%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
19
Increased
22
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Blackstone Inc
Blackstone Inc
New York
+$12.4M
2
BBA
Baker Bros. Advisors
New York
+$6.21M
3
VC
Vivo Capital
California
+$6.21M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.66M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4.41M
2
EAM
Eventide Asset Management
Massachusetts
-$659K
3
Marshall Wace
Marshall Wace
United Kingdom
-$93.8K
4
Renaissance Technologies
Renaissance Technologies
New York
-$49.1K
5
FHA
Flagship Harbor Advisors
Massachusetts
-$9.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$790K +$278K +69,716 +80%
Citigroup
27
Citigroup
New York
$635K +$486K +121,782 +2,687%
LP
28
LMR Partners
United Kingdom
$628K +$99.5K +24,939 +25%
Millennium Management
29
Millennium Management
New York
$412K +$74.8K +18,760 +30%
Morgan Stanley
30
Morgan Stanley
New York
$324K +$222K +55,626 +627%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$317K +$251K +62,995 New
Jane Street
32
Jane Street
New York
$316K +$194K +48,564 +340%
Citadel Advisors
33
Citadel Advisors
Florida
$313K +$248K +62,276 New
Renaissance Technologies
34
Renaissance Technologies
New York
$261K -$49.1K -12,315 -19%
Charles Schwab
35
Charles Schwab
California
$215K +$44K +11,031 +35%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$198K +$60K +15,055 +62%
6CM
37
683 Capital Management
New York
$191K +$152K +38,039 New
MFS
38
Mirabella Financial Services
United Kingdom
$153K +$121K +30,444 New
SIC
39
Salem Investment Counselors
North Carolina
$151K – – –
JF
40
Jump Financial
Illinois
$147K +$116K +29,200 New
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$145K +$115K +28,793 New
Marshall Wace
42
Marshall Wace
United Kingdom
$142K -$93.8K -23,520 -45%
Man Group
43
Man Group
United Kingdom
$127K +$101K +25,305 New
NCM
44
New Capital Management
Texas
$122K – – –
Barclays
45
Barclays
United Kingdom
$91.7K +$71.2K +17,851 +4,773%
BFM
46
Boothbay Fund Management
New York
$86.2K +$68.3K +17,130 New
BRWA
47
B. Riley Wealth Advisors
Florida
$75K +$59.5K +14,918 New
LIP
48
Lighthouse Investment Partners
Florida
$73.8K +$58.5K +14,662 New
UBS Group
49
UBS Group
Switzerland
$59.5K +$18.3K +4,591 +64%
FHA
50
Flagship Harbor Advisors
Massachusetts
$57.8K -$9.97K -2,500 -18%
1
2
3

CMPX Hedge Fund Activity: Q4 2022 in Review

55 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q4 2022, worth a combined $401M — up 287% from $104M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CMPX positions and 1 closed out — a net gain of 18 holders — while 22 added to existing stakes and 5 trimmed.

The largest buyer was Blackstone Inc, adding an estimated $12.4M. The largest seller was Janus Henderson Group, cutting an estimated $4.41M.

  • 55 institutional investors held Compass Therapeutics (CMPX) as of Q4 2022, up from 38 in Q3 2022.
  • Funds reported $401M of Compass Therapeutics stock for Q4 2022, up 287% quarter-over-quarter.
  • 19 funds opened new Compass Therapeutics positions in Q4 2022 and 1 closed out, a net change of +18 holders.
  • The largest Compass Therapeutics buyer in Q4 2022 was Blackstone Inc, an estimated $12.4M added.
  • The largest Compass Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $4.41M sold.

Based on aggregated 13F filings for Q4 2022.